Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M911Revenue $M55.5Net Margin (%)-67.6Z-Score0.1
Enterprise Value $M789EPS $-0.3Operating Margin %-55.0F-Score5
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-67.6Higher ROA y-yY
Price/Book40.910-y EBITDA Growth Rate %-26.9Quick Ratio7.1Cash flow > EarningsY
Price/Sales15.75-y EBITDA Growth Rate %-23.2Current Ratio7.1Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-22.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-183.1Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M124ROI % (ttm)-167.3Gross Margin Increase y-yN

Gurus Latest Trades with OREX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OREXGeorge Soros 2012-06-30 Sold Out -0.03%$3.16 - $6.37
($3.76)
$ 7.4049%Sold Out0
OREXGeorge Soros 2012-03-31 Buy 0.03%$1.68 - $5.01
($3.11)
$ 7.4058%New holding500,000
OREXJean-Marie Eveillard 2010-09-30 Sold Out -0.01%$3.9 - $6.77
($4.98)
$ 7.4033%Sold Out0
OREXJean-Marie Eveillard 2010-06-30 Add$4.05 - $7.04
($5.57)
$ 7.4025%Add 74.07%470,000
OREXJean-Marie Eveillard 2010-03-31 Add$5.9 - $7.66
($6.55)
$ 7.4011%Add 22.73%270,000
OREXJean-Marie Eveillard 2009-12-31 Add0.01%$6.44 - $9.39
($7.57)
$ 7.40-2%Add 83.33%220,000
OREXJean-Marie Eveillard 2009-09-30 Buy 0.01%$5.2 - $10.34
($7.89)
$ 7.40-7%New holding120,000
OREXBill Gates 2009-06-30 Sold Out $1.89 - $5.21
($3.19)
$ 7.4057%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OREX is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


OREX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Booth Mark DChief Commercial Officer 2015-02-26Sell50,000$5.6830.28 view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-12-02Sell22,643$623.33 view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-11-25Sell31,388$5.8326.93 view
BOCK LOUIS CDirector 2014-11-18Buy1,325$5.5832.62 view
BOCK LOUIS CDirector 2014-11-12Buy27,052$5.5732.85 view
Turner Heather DVP, Gen. Counsel & Secretary 2014-09-22Sell300,000$4.4765.55 view
NARACHI MICHAELPresident and CEO 2014-09-15Buy50,000$4.7854.81 view
Hagan Joseph PSr. VP, Corporate Development 2014-09-15Buy5,000$4.6957.78 view
Hagan Joseph PChief Business Officer 2013-07-31Sell12,000$7.8-5.13 view
Hagan Joseph PChief Business Officer 2013-07-26Sell10,000$7.40 view

Press Releases about OREX :

Quarterly/Annual Reports about OREX:

News about OREX:

Articles On GuruFocus.com
Oxford Industries (OXM) Solid Growth Metrics, Orexigen Therapeutics (OREX) European Anti-Obesity App Mar 27 2015 
Orexigen Therapeutics' Bright Future Mar 03 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, an Jul 15 2012 
Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therap Jul 08 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 
Vivus Could Rocket on Success of Qnexa Apr 13 2012 
Steve Cohen Bets On Orexigen Ahead of FDA Approval Jan 31 2011 
Orexigen Therapeutics Inc. Reports Operating Results (10-Q) Nov 04 2010 


More From Other Websites
Orexigen's Obesity Drug Contrave Faces Generic Threat - Analyst Blog Apr 23 2015
TRADING ALERT: The Rosen Law Firm Reminds Orexigen Therapeutics, Inc. Investors of the Important May... Apr 23 2015
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Apr 23 2015
Orexigen Announces Receipt of Paragraph IV Certification Notice Apr 22 2015
Orexigen Announces Receipt of Paragraph IV Certification Notice Apr 22 2015
7:30 am Orexigen Therapeutics announces it has received notification of a Paragraph IV certification... Apr 22 2015
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notify Investors of Class Action Involving... Apr 21 2015
Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action... Apr 20 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Orexigen Therapeutics, Inc. of... Apr 15 2015
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From... Apr 14 2015
Law Offices of Howard G. Smith Reminds Investors of Orexigen Therapeutics, Inc. of the May 11, 2015... Apr 13 2015
OREXIGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds... Apr 10 2015
Orexigen Therapeutics to Speak at the Needham Healthcare Conference Apr 10 2015
Orexigen Therapeutics to Speak at the Needham Healthcare Conference Apr 10 2015
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on Their Investment in... Apr 10 2015
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Orexigen Therapeutics, Inc. of... Apr 10 2015
5 stocks to watch Apr 08 2015
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From... Apr 06 2015
EQUITY ALERT: The Rosen Law Firm Reminds Orexigen Therapeutics, Inc. Investors of Important Deadline... Apr 03 2015
DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholders Of Orexigen Therapeutics, Inc. Of... Apr 02 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK